This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Tomio Sasao: Innovator in Pharmaceutical Chemistry
Introduction
Tomio Sasao is a notable inventor based in Hiratsuka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cephalosporin derivatives. His work has implications for antibiotic development and medical treatments.
Latest Patents
Tomio Sasao holds a patent for a process related to the preparation of 3-alkoxymethyl cephalosporin derivatives. The patent describes a compound of formula (I) that is prepared by reacting 7-aminocephalosporanic acid or a salt thereof with a solution comprising a compound of formula ROSO.sub.3 H in a compound of formula ROH. This process is conducted in the presence of at least one compound of formula B(OR).sub.3 or compound of formula CH.sub.2 (OR).sub.2. In these compounds, R represents an alkyl group having from 1 to 6 carbon atoms. This innovation is crucial for advancing antibiotic therapies.
Career Highlights
Tomio Sasao is associated with Sankyo Company, Limited, where he has been instrumental in research and development. His expertise in pharmaceutical chemistry has led to advancements in drug formulation and efficacy. His work has been recognized within the industry for its potential impact on healthcare.
Collaborations
Tomio Sasao has collaborated with notable colleagues such as Syuzi Sayama and Yasuo Takahashi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmaceutical research.
Conclusion
Tomio Sasao's contributions to the field of pharmaceutical chemistry, particularly through his patent on cephalosporin derivatives, highlight his role as an innovator. His work continues to influence the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
